Welltower Inc. $WELL Shares Sold by Ingalls & Snyder LLC

Ingalls & Snyder LLC lowered its position in shares of Welltower Inc. (NYSE:WELL) by 1.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,790 shares of the real estate investment trust’s stock after selling 70 shares during the period. Ingalls & Snyder LLC’s holdings in Welltower were worth $890,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Wellington Management Group LLP increased its position in Welltower by 14.0% in the 1st quarter. Wellington Management Group LLP now owns 21,289,684 shares of the real estate investment trust’s stock valued at $3,261,792,000 after acquiring an additional 2,614,562 shares during the period. Price T Rowe Associates Inc. MD increased its position in Welltower by 41.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,923,852 shares of the real estate investment trust’s stock valued at $1,367,226,000 after acquiring an additional 2,622,384 shares during the period. Northern Trust Corp increased its position in Welltower by 0.4% in the 1st quarter. Northern Trust Corp now owns 8,467,221 shares of the real estate investment trust’s stock valued at $1,297,263,000 after acquiring an additional 36,725 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Welltower by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,164,840 shares of the real estate investment trust’s stock valued at $1,250,935,000 after acquiring an additional 532,135 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in Welltower by 14.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 6,956,594 shares of the real estate investment trust’s stock valued at $1,065,820,000 after acquiring an additional 877,856 shares during the period. Institutional investors and hedge funds own 94.80% of the company’s stock.

Welltower Price Performance

Shares of NYSE:WELL opened at $178.04 on Monday. The business’s 50 day simple moving average is $170.05 and its 200-day simple moving average is $159.42. The firm has a market capitalization of $119.08 billion, a price-to-earnings ratio of 100.59, a price-to-earnings-growth ratio of 1.99 and a beta of 0.92. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.19 and a quick ratio of 4.19. Welltower Inc. has a 12 month low of $123.11 and a 12 month high of $180.40.

Welltower (NYSE:WELL) last announced its quarterly earnings results on Monday, July 28th. The real estate investment trust reported $1.28 EPS for the quarter, topping the consensus estimate of $1.22 by $0.06. The business had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.49 billion. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The company’s quarterly revenue was up 39.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.05 EPS. As a group, equities analysts forecast that Welltower Inc. will post 4.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on WELL. UBS Group began coverage on Welltower in a research report on Friday, September 19th. They issued a “buy” rating and a $195.00 price target on the stock. Scotiabank boosted their price target on Welltower from $181.00 to $182.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. KeyCorp boosted their target price on Welltower from $150.00 to $200.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 23rd. Cantor Fitzgerald initiated coverage on Welltower in a research report on Wednesday, October 1st. They set an “overweight” rating and a $195.00 target price on the stock. Finally, Evercore ISI boosted their target price on Welltower from $175.00 to $183.00 and gave the stock an “in-line” rating in a research report on Monday, September 15th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $186.43.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.